← 產業報告目錄
Continuous Bioprocessing Market Size, Share & Trends Analysis Report, By Product (Chromatography Systems & Consumables, Filtration Systems & Devices, Bioreactor, Cell Culture Media & Reagents and Others) By Process (Upstream, Downstream) By Application (Monoclonal Antibodies, Vaccines, Cell & Gene Therapy, Others) By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations), By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-15頁數 180報告編號 INSIGHTACE-948de1d684
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Continuous Bioprocessing Market on a global scale was estimated at USD 304.52 Mn in 2024 and is poised to attain USD 1901.07 Mn by 2034, with a projected CAGR of 20.2% between 2025 and 2034.
The Continuous Bioprocessing sector involves a technology utilized in the production of biopharmaceuticals, wherein manufacturing operations are interconnected seamlessly with minimal hold volume. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Continuous Bioprocessing Market Snapshot
Chapter 4. Global Continuous Bioprocessing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis
5.1. by Product & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product:
5.2.1. Chromatography Systems and Consumables
5.2.2. Filtration Systems and Devices
5.2.3. Bioreactors
5.2.4. Cell Culture Media, Cell Lines, Buffers, and Reagents
5.2.5. Other Products
Chapter 6. Market Segmentation 2: by Process Estimates & Trend Analysis
6.1. by Process & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Process:
6.2.1. Downstream Bioprocess
6.2.2. Upstream Bioprocess
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Monoclonal Antibodies
7.2.2. Vaccines
7.2.3. Cell and Gene Therapy
7.2.4. Other Applications
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Academic and Research Institutes
8.2.3. Contract Research Organizations
Chapter 9. Continuous Bioprocessing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.1.2. North America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Process, 2021-2034
9.1.3. North America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.4. North America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.1.5. North America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.2. Europe Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Process, 2021-2034
9.2.3. Europe Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. Europe Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.2.5. Europe Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.2. Asia Pacific Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Process, 2021-2034
9.3.3. Asia-Pacific Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Asia Pacific Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3.5. Asia Pacific Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.2. Latin America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Process, 2021-2034
9.4.3. Latin America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Latin America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4.5. Latin America Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.2. Middle East & Africa Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Process, 2021-2034
9.5.3. Middle East & Africa Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Middle East & Africa Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5.5. Middle East & Africa Continuous Bioprocessing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. 3M
10.2.2. Bio-Rad Laboratories, Inc.
10.2.3. Thermo Fisher Scientific, Inc.
10.2.4. Merck KGaA
10.2.5. Sartorius AG
10.2.6. Danaher Corporation
10.2.7. Corning Incorporated
10.2.8. Repligen Corporation
10.2.9. Eppendorf AG
10.2.10. Entegris, Inc.
10.2.11. Meissner Filtration Products Inc.
10.2.12. Kuhner AG
10.2.13. OmniBRx Biotechnologies Pvt Ltd.
10.2.14. Bionet
10.2.15. Solesis Medical
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們